Artiva Biotherapeutics Receives Immunology Innovation of the Year in the 2023 BioTech Breakthrough Awards Program
SAN DIEGO--(BUSINESS WIRE)--Nov 8, 2023--<a ...
SAN DIEGO--(BUSINESS WIRE)--Nov 8, 2023--<a ...
--(BUSINESS WIRE)--Nov 8, 2023--<em>WHAT:</em> Serimmune will discuss its Serum Epitope Repertoire Analysis (SERA) platform and how it can be applied in various studies to gain insight into past and present humoral immune responses in individuals and cohorts. The new ...
AUSTIN, Texas--(BUSINESS WIRE)--Nov 8, 2023--<a ...
SANTA CRUZ, Calif. & CAMPBELL, Calif.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 8, 2023--Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics designed to modulate the tumor microenvironment to elicit a potent and durable anti-tumor response, today announced that company leadership will present ...
WALTHAM, Mass.--(BUSINESS WIRE)--Nov 8, 2023--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in a fireside chat ...
